Retrospective review reveals anxiety and depression worsen adhesive capsulitis outcomes, suggesting a need for multidisciplinary care.
Key Points
This study aims to explore the impact of anxiety and depression on the clinical outcomes of adhesive capsulitis over two years.
Conducted a retrospective review using the PearlDiver national-claims database (2010-2023).
Patients were grouped based on anxiety or depression diagnoses before their adhesive capsulitis diagnosis, and propensity score matching was employed.
Multivariate linear and logistic regression assessed anxiety/depression as a predictor of 2-year outcomes.
17.1% of the 1,021,051 patients had anxiety/depression before diagnosis.
Patients with anxiety/depression were 21% more likely to receive steroid injections (OR 1.21, p < 0.001), 29% more likely to have prolonged opioid use (OR 1.29, p < 0.001), and 28% more likely to report persistent shoulder pain (OR 1.28, p < 0.001).
Psychotherapy was linked to decreased prolonged opioid use, though both treatment types generally did not improve overall outcomes.